STAT+: Concerns grow on safety issues tied to Neurocrine Biosciences rare disease drug
STAT News · LC · trust 43/100
Patient advocates and some experts are expressing growing alarm over the perceived risks of a rare disease drug sold by Neurocrine Biosciences.
Read the original at STAT News →
Open in TruthVane →